➤ Get the DrugPatentWatch Daily Briefing

Get Daily Updates on Generic Entry, Litigation, Biosimilars, and more …

Serving leading biopharmaceutical companies globally:

McKesson
Boehringer Ingelheim
Moodys
Johnson and Johnson
Harvard Business School
AstraZeneca

Last Updated: June 23, 2021

DrugPatentWatch Database Preview

Patent Applications for rapacuronium bromide


Email this page to a colleague

« Back to Dashboard

US Patent Applications for rapacuronium bromide

US Patent Application Patent No. Title Patent Filing Date Patent Application Status Status Updated
  Get Started Free   Get Started Free Buccal, polar and non-polar spray or capsule containing drugs for treating disorders of the central nervous system 2002-08-29 Abandoned -- Failure to Respond to an Office Action 2009-03-02
  Get Started Free   Get Started Free METHODS FOR PREPARING PHARMACEUTICAL FORMULATIONS 2002-06-13 Patent Expired Due to NonPayment of Maintenance Fees Under 37 CFR 1.362 2013-07-29
  Get Started Free   Get Started Free Buccal, polar and non-polar spray or capsule containing drugs for treating pain 2002-08-29 Abandoned -- Failure to Respond to an Office Action 2009-03-02
  Get Started Free   Get Started Free 6-MERCAPTO-CYCLODEXTRIN DERIVATIVES: REVERSAL AGENTS FOR DRUG-INDUCED NEUROMUSCULAR BLOCK 2003-06-23 Patented Case 2005-09-07
  Get Started Free   Get Started Free 2-ALKYLATED-CYCLODEXTRIN DERIVATIVES: REVERSAL AGENTS FOR DRUG-INDUCED NEUROMUSCULAR BLOCK 2003-12-08 Patented Case 2006-03-22
  Get Started Free   Get Started Free Rail stent 2003-11-14 Abandoned -- Failure to Respond to an Office Action 2010-09-01
  Get Started Free   Get Started Free BUCCAL, POLAR AND NON-POLAR SPRAY OR CAPSULE CONTAINING DRUGS FOR TREATING DISORDERS OF THE CENTRAL NERVOUS SYSTEM 2003-12-04 Patented Case 2005-11-30
>US Patent Application >Patent No. >Title >Patent Filing Date >Patent Application Status >Status Updated

WIPO Patent Applications for rapacuronium bromide

Make Better Decisions: Try a trial or see plans & pricing

Serving leading biopharmaceutical companies globally:

Baxter
McKinsey
Dow
Moodys
Colorcon
Harvard Business School

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.